Icad Market Capitalization from 2010 to 2024
| ICAD Stock | USD 1.73 0.04 2.26% |
Check Icad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Icad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 388.6 K, Interest Expense of 15.2 K or Total Revenue of 23.3 M, as well as many indicators such as Price To Sales Ratio of 5.08, Dividend Yield of 0.0018 or PTB Ratio of 1.29. Icad financial statements analysis is a perfect complement when working with Icad Valuation or Volatility modules.
Icad | Market Capitalization |
Latest Icad's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of icad inc over the last few years. It is Icad's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Icad's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 46.65 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Icad Market Capitalization Regression Statistics
| Arithmetic Mean | 64,972,618 | |
| Geometric Mean | 63,747,275 | |
| Coefficient Of Variation | 20.81 | |
| Mean Deviation | 10,411,310 | |
| Median | 61,734,496 | |
| Standard Deviation | 13,518,263 | |
| Sample Variance | 182.7T | |
| Range | 49.2M | |
| R-Value | (0.52) | |
| Mean Square Error | 142.7T | |
| R-Squared | 0.27 | |
| Significance | 0.04 | |
| Slope | (1,584,285) | |
| Total Sum of Squares | 2558.4T |
Icad Market Capitalization History
About Icad Financial Statements
Icad stakeholders use historical fundamental indicators, such as Icad's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Icad investors may analyze each financial statement separately, they are all interrelated. For example, changes in Icad's assets and liabilities are reflected in the revenues and expenses on Icad's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in icad inc. Please read more on our technical analysis and fundamental analysis pages.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:Check out the analysis of Icad Correlation against competitors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.20) | Revenue Per Share 0.718 | Quarterly Revenue Growth 0.206 | Return On Assets (0.08) | Return On Equity (0.15) |
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.